Co-Authors
This is a "connection" page, showing publications co-authored by Dhruva Chaudhry and Pawan Singh.
Connection Strength
1.970
-
Tocilizumab and COVID-19. Indian J Crit Care Med. 2020 Sep; 24(9):741-743.
Score: 0.901
-
COVID-19: Winter is COMING! Indian J Crit Care Med. 2020 Nov; 24(Suppl 5):S223-S224.
Score: 0.228
-
Modified Barrier Enclosure for Noninvasive Respiratory Support in COVID-19 Outbreak. Indian J Crit Care Med. 2020 Sep; 24(9):835-837.
Score: 0.225
-
Ultraviolet Box: An Innovative In-house Use of Ultraviolet Irradiation for Conservation of Respirators in COVID-19 Pandemic. Indian J Crit Care Med. 2020 Aug; 24(8):713-715.
Score: 0.224
-
Hydroxychloroquine for chemoprophylaxis in COVID-19: A case of motivated perception? Indian J Med Res. 2020 Jul & Aug; 152(1 & 2):116-118.
Score: 0.223
-
Tocilizumab plus standard care versus standard care in patients in India with moderate to severe COVID-19-associated cytokine release syndrome (COVINTOC): an open-label, multicentre, randomised, controlled, phase 3 trial. Lancet Respir Med. 2021 05; 9(5):511-521.
Score: 0.058
-
Critical Care for COVID-19 Affected Patients: Updated Position Statement of the Indian Society of Critical Care Medicine. Indian J Crit Care Med. 2020 Nov; 24(Suppl 5):S225-S230.
Score: 0.057
-
Critical Care for COVID-19 Affected Patients: Position Statement of the Indian Society of Critical Care Medicine. Indian J Crit Care Med. 2020 Apr; 24(4):222-241.
Score: 0.055